Localization and physiological roles of metabotropic glutamate receptors in the direct and indirect pathways of the basal ganglia
- PMID: 12373536
- DOI: 10.1007/s00726-001-0127-1
Localization and physiological roles of metabotropic glutamate receptors in the direct and indirect pathways of the basal ganglia
Abstract
Our current understanding of the circuitry of the basal ganglia, and the pathophysiology of Parkinson's disease has led to major breakthroughs in the treatment of this debilitating movement disorder. Unfortunately, there are significant problems with the currently available pharmacological therapies that focus on dopamine replacement or dopaminergic agonists. Because of this, much effort has been focused on developing novel targets for the treatment of Parkinson's disease. The metabotropic glutamate receptors are a family of G-protein coupled receptors activated by glutamate. These receptors are differentially distributed throughout the basal ganglia in a manner suggesting that they may provide novel targets for the treatment of movement disorders. In this review we summarize anatomical and physiological data from our work and the work of other laboratories describing the distribution and physiological roles of metabotropic glutamate receptors in the basal ganglia with emphasis on possible therapeutic targets.
Similar articles
-
Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.Prog Brain Res. 2008;172:423-63. doi: 10.1016/S0079-6123(08)00921-7. Prog Brain Res. 2008. PMID: 18772045 Review.
-
Metabotropic glutamate receptors in the basal ganglia motor circuit.Nat Rev Neurosci. 2005 Oct;6(10):787-98. doi: 10.1038/nrn1763. Nat Rev Neurosci. 2005. PMID: 16276355 Review.
-
Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.Prog Brain Res. 2008;172:479-94. doi: 10.1016/S0079-6123(08)00923-0. Prog Brain Res. 2008. PMID: 18772047 Review.
-
Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains.Mov Disord. 2008;23 Suppl 3:S534-47. doi: 10.1002/mds.22027. Mov Disord. 2008. PMID: 18781680 Review.
-
Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease.Amino Acids. 2007 Feb;32(2):189-95. doi: 10.1007/s00726-006-0320-3. Epub 2006 May 22. Amino Acids. 2007. PMID: 16715415 Review.
Cited by
-
Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.ACS Chem Neurosci. 2016 Sep 21;7(9):1201-11. doi: 10.1021/acschemneuro.6b00036. Epub 2016 Aug 5. ACS Chem Neurosci. 2016. PMID: 27441572 Free PMC article.
-
Study on Effect of Striatal mGluR2/3 in Alleviating Motor Dysfunction in Rat PD Model Treated by Exercise Therapy.Front Aging Neurosci. 2019 Oct 2;11:255. doi: 10.3389/fnagi.2019.00255. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31632264 Free PMC article.
-
NCAM function in the adult brain: lessons from mimetic peptides and therapeutic potential.Neurochem Res. 2013 Jun;38(6):1163-73. doi: 10.1007/s11064-013-1007-2. Epub 2013 Mar 14. Neurochem Res. 2013. PMID: 23494903 Review.
-
Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson's disease.PLoS One. 2014 Dec 16;9(12):e114086. doi: 10.1371/journal.pone.0114086. eCollection 2014. PLoS One. 2014. PMID: 25513815 Free PMC article.
-
Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity.Mol Pharmacol. 2010 Dec;78(6):1105-23. doi: 10.1124/mol.110.067207. Epub 2010 Oct 5. Mol Pharmacol. 2010. PMID: 20923853 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical